Androski Lindsay sold ABUS
September 18, 2026 · Form 4 insider transaction
Androski Lindsay sold 82,527 shares of Arbutus Biopharma Corporation at $5.07 per share, a transaction worth $418.4K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
82,527
Price
$5.07
Total value
$418.4K
InsiderAndroski Lindsay
Role—
SecurityCommon Shares
Transaction codeF: Shares withheld for taxes
Transaction dateSeptember 18, 2026
Filing dateSeptember 23, 2026
Shares owned after72,337
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person exercised options on September 18, 2026. The Issuer withheld an aggregate of 82,527 shares otherwise issuable upon the exercises to satisfy the aggregate exercise prices.